{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/97577"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/97577","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Effects of inulin supplementation on markers of mineral and bone metabolism and the gut microbiota in hemodialysis patients","abstract":"Up to 80% of patients with chronic kidney disease (CKD) have some degree of mineral and bone disorder (MBD), which is associated with higher morbidity and mortality, specifically from cardiovascular causes. Despite the pharmacological treatment for MBD, its prevalence remains high, especially for patients with kidney failure undergoing chronic hemodialysis (HD) treatment. Restriction of dietary phosphorus along with phosphate binders represents an important part of the treatment of MBD. However, due to this restriction along with a potassium-restricted diet, HD patients limit a variety of foods that contain dietary fiber. The supplementation of dietary fiber, specifically fermentable fiber, has been explored in other clinical populations with MBD, such as female adolescents and postmenopausal women. While it is known that this supplementation leads to a higher production of short-chain fatty acids (SCFA) by the gut microbiota and an effect on the absorption of calcium and magnesium, this mechanism remains unexplored in HD patients. The supplementation of inulin, a fermentable fiber, represents a feasible and low-cost co-adjuvant therapy for the treatment of MBD in HD patients. Therefore, the objective of this dissertation is to examine the effects of the supplementation of inulin on bone and mineral metabolism and the gut microbiota in HD patients.","abstract_html":"Up to 80% of patients with chronic kidney disease (CKD) have some degree of mineral and bone disorder (MBD), which is associated with higher morbidity and mortality, specifically from cardiovascular causes. Despite the pharmacological treatment for MBD, its prevalence remains high, especially for patients with kidney failure undergoing chronic hemodialysis (HD) treatment. Restriction of dietary phosphorus along with phosphate binders represents an important part of the treatment of MBD. However, due to this restriction along with a potassium-restricted diet, HD patients limit a variety of foods that contain dietary fiber. The supplementation of dietary fiber, specifically fermentable fiber, has been explored in other clinical populations with MBD, such as female adolescents and postmenopausal women. While it is known that this supplementation leads to a higher production of short-chain fatty acids (SCFA) by the gut microbiota and an effect on the absorption of calcium and magnesium, this mechanism remains unexplored in HD patients. The supplementation of inulin, a fermentable fiber, represents a feasible and low-cost co-adjuvant therapy for the treatment of MBD in HD patients. Therefore, the objective of this dissertation is to examine the effects of the supplementation of inulin on bone and mineral metabolism and the gut microbiota in HD patients.","abstract_has_math":false,"creators":["Biruete, Annabel"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Nutritional Sciences","degree_department":null,"school":null,"contributors":["Wilund, Kenneth","Swanson, Kelly","Woods, Jeffrey","Pan, Yuan-Xiang"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017-08-10T19:51:58Z","date_published":"2017-08-10T19:51:58Z","updated_at":"2026-07-22T22:24:34Z","subjects":["Hemodialysis","Kidney failure","Nutrition","Mineral and bone metabolism","Gut microbiota"],"languages":["en"],"rights":["Copyright 2017 Annabel Biruete"],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/2142/97577","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Wilund, Kenneth","Swanson, Kelly","Woods, Jeffrey","Pan, Yuan-Xiang"]},{"key":"dc:creator","label":"Author","values":["Biruete, Annabel"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2017-08-10T19:51:58Z","2019-08-11T09:15:39Z","2017-04-18","2017-05"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Nutritional Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Hemodialysis","Kidney failure","Nutrition","Mineral and bone metabolism","Gut microbiota"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright 2017 Annabel Biruete"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/97577"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Up to 80% of patients with chronic kidney disease (CKD) have some degree of mineral and bone disorder (MBD), which is associated with higher morbidity and mortality, specifically from cardiovascular causes. Despite the pharmacological treatment for MBD, its prevalence remains high, especially for patients with kidney failure undergoing chronic hemodialysis (HD) treatment. Restriction of dietary phosphorus along with phosphate binders represents an important part of the treatment of MBD. However, due to this restriction along with a potassium-restricted diet, HD patients limit a variety of foods that contain dietary fiber. The supplementation of dietary fiber, specifically fermentable fiber, has been explored in other clinical populations with MBD, such as female adolescents and postmenopausal women. While it is known that this supplementation leads to a higher production of short-chain fatty acids (SCFA) by the gut microbiota and an effect on the absorption of calcium and magnesium, this mechanism remains unexplored in HD patients. The supplementation of inulin, a fermentable fiber, represents a feasible and low-cost co-adjuvant therapy for the treatment of MBD in HD patients. Therefore, the objective of this dissertation is to examine the effects of the supplementation of inulin on bone and mineral metabolism and the gut microbiota in HD patients.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2019-05-01","The student, Annabel Biruete, accepted the attached license on 2017-04-15 at 17:02.","The student, Annabel Biruete, submitted this Dissertation for approval on 2017-04-15 at 18:09.","This Dissertation was approved for publication on 2017-04-18 at 09:45.","DSpace SAF Submission Ingestion Package generated from Vireo submission #10781 on 2017-08-10 at 14:30:50","Made available in DSpace on 2017-08-10T19:51:58Z (GMT). No. of bitstreams: 3 BIRUETE-DISSERTATION-2017.pdf: 1782659 bytes, checksum: d699815e1bad4a44d16c7be4cdeab2a1 (MD5) Copyright clearance.pdf: 108396 bytes, checksum: 444a74d46777e01e2b045359f9d96a73 (MD5) LICENSE.txt: 4212 bytes, checksum: 99bc47bb4cec3ae882fadea047b3eeea (MD5) Previous issue date: 2017-04-18","Embargo set by: Colleen Fallaw for item 102630 Lift date: 2019-08-10T21:25:30Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 102630 on 2019-08-11T09:15:39Z."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Effects of inulin supplementation on markers of mineral and bone metabolism and the gut microbiota in hemodialysis patients"]}]}],"canonical_facts":{"dc:contributor":["Wilund, Kenneth","Swanson, Kelly","Woods, Jeffrey","Pan, Yuan-Xiang"],"dc:creator":["Biruete, Annabel"],"dc:date":["2017-08-10T19:51:58Z","2019-08-11T09:15:39Z","2017-04-18","2017-05"],"dc:description":["Up to 80% of patients with chronic kidney disease (CKD) have some degree of mineral and bone disorder (MBD), which is associated with higher morbidity and mortality, specifically from cardiovascular causes. Despite the pharmacological treatment for MBD, its prevalence remains high, especially for patients with kidney failure undergoing chronic hemodialysis (HD) treatment. Restriction of dietary phosphorus along with phosphate binders represents an important part of the treatment of MBD. However, due to this restriction along with a potassium-restricted diet, HD patients limit a variety of foods that contain dietary fiber. The supplementation of dietary fiber, specifically fermentable fiber, has been explored in other clinical populations with MBD, such as female adolescents and postmenopausal women. While it is known that this supplementation leads to a higher production of short-chain fatty acids (SCFA) by the gut microbiota and an effect on the absorption of calcium and magnesium, this mechanism remains unexplored in HD patients. The supplementation of inulin, a fermentable fiber, represents a feasible and low-cost co-adjuvant therapy for the treatment of MBD in HD patients. Therefore, the objective of this dissertation is to examine the effects of the supplementation of inulin on bone and mineral metabolism and the gut microbiota in HD patients.","Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2019-05-01","The student, Annabel Biruete, accepted the attached license on 2017-04-15 at 17:02.","The student, Annabel Biruete, submitted this Dissertation for approval on 2017-04-15 at 18:09.","This Dissertation was approved for publication on 2017-04-18 at 09:45.","DSpace SAF Submission Ingestion Package generated from Vireo submission #10781 on 2017-08-10 at 14:30:50","Made available in DSpace on 2017-08-10T19:51:58Z (GMT). No. of bitstreams: 3 BIRUETE-DISSERTATION-2017.pdf: 1782659 bytes, checksum: d699815e1bad4a44d16c7be4cdeab2a1 (MD5) Copyright clearance.pdf: 108396 bytes, checksum: 444a74d46777e01e2b045359f9d96a73 (MD5) LICENSE.txt: 4212 bytes, checksum: 99bc47bb4cec3ae882fadea047b3eeea (MD5) Previous issue date: 2017-04-18","Embargo set by: Colleen Fallaw for item 102630 Lift date: 2019-08-10T21:25:30Z Reason: Author requested closed access (OA after 2yrs) in Vireo ETD system","Limited Restriction Lifted for Item 102630 on 2019-08-11T09:15:39Z."],"dc:format":["application/pdf"],"dc:identifier":["http://hdl.handle.net/2142/97577"],"dc:language":["en"],"dc:rights":["Copyright 2017 Annabel Biruete"],"dc:subject":["Hemodialysis","Kidney failure","Nutrition","Mineral and bone metabolism","Gut microbiota"],"dc:title":["Effects of inulin supplementation on markers of mineral and bone metabolism and the gut microbiota in hemodialysis patients"],"dc:type":["text"],"thesis:degree_discipline":["Nutritional Sciences"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:24:34Z"}